Diagnostic accuracy of optical coherence tomography for patients with Ureteral cancer

Not Applicable

Recruiting

• Conditions: reteral tumor, Ureteral cancer

• Registration Number: JPRN-UMIN000049594
• Lead Sponsor: rology, Nara Medical University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-12-01
• Last Update Posted: 17 October 2023
• Study Completion: 2025-10-31

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients who cannot agree with enrollment of the study by his/her own intention 2) Inappropriate for the enrolment by the judgement of the physician because of psychosis or psychiatric symptoms

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The diagnostic accuracy of optical coherence tomography in distinguishing Ta/Tis/T1 tumors and T2/T3 cancers.

Secondary Outcome Measures

Name	Time	Method
1) The diagnostic accuracy of optical coherence tomography in determining Ta, Tis, T1, T2, and T3 ureteral cancers. 2) The diagnostic accuracy of optical coherence tomography in distinguishing Ta/Tis/T1/T2 tumors and T3 ureteral cancers. 3) The safety of optical coherence tomography test in patients with ureteral cancer (CTCAE ver 5.0). 4) Factors associated with misdiagnosis of optical coherence tomography in ureteral cancer T category.